Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does the trend continue and we see another new 52 week low today with this pos?
Every day is a new 52 week low. This company and especially this management team is a joke. Nobody should waste their money on this. They shouldn't be allowed to operate any public company.
So they can dump more shares into the market and lower the pps even more? Yes you can buy at. 006 or wait for the company to dump more and buy at .0006.
Wonder if they issued another toxic note?
All we need is a $50-100M deal with a German pharmaceutical company for the polarization technology and off we go.
Is it possible, the press release was to try to get support for their note holders dumping?
Is she finally ready to pop???
There's a little positive movement so far this morning. Let's hope the note holders don't hammer us back down.
Those toxic notes holders sure do need to get rid of those shares quickly. Another new 52 week low today. This management team is terrible!!
Every time there's a bid, it gets taken out. My guess is company received the financing with another toxic loan. Company never pr's these as they know it's toxic and don't say anything about it. Sadly, even the investor knows the management team sucks and dumps the shares asap.
This is what happens when the company issue convertible notes at 1/2 the stock price. Last I saw price on notes issued, conversion was .015. These toxic notes need to stop. If they have that much going for them in terms of selling the scorpion venum and other products, why? Mgmt is clueless with being a pubco. Or they want to issue stock and reverse later.
Did the company issue convertible notes with a conversion price of .015?
Bob was not only a complete failure as CEO, he is also a scumbag. He had stated previously that Ironridge was selling more than they were supposed to and caused significant reduction in the pps. He was pulling the stock sales sheets to prove they were the ones driving the price lower. Now he states they did nothing wrong so he can have his stock freed up? Wtf. This scumbag is screwing over every single shareholder to look out for himself. SCUMBAG!!!!
BS schneiderman is a complete failure as the CEO. He needs to step down asap.
Hope this new guy Triggs will become the CEO and bring some credibility and experience to the position. Something current mgmt is severely lacking. Then we would just need a new CFO that could file on time.
Hopefully, he will become the new CEO and replace bss. he probably has more credibility in his pinkie. then we would just need to find a CFO that can get the job done.
trying to find the post where someone stated that bss doesn't need the money and this is just a challenge for him that he enjoys. please tell the 70?? year old to take up golf if he wants a challenge. imo, his on the job training in pharmaceuticals and on the job training as pubco ceo has hurt shareholders the most. scrc NEEDS a real pharma ceo.
imo, some of these guys aren't going anywhere. once they realized how clueless bss was at running a pubco, they dug right in. i believe ab actually set up a new company for a sales team because he saw the excessive commissions bss was paying out. until bss is replaced by a ceo with an education and experience in pharma, you will always have these people around.
Hopefully,whenever the K is filed, the Company will discuss the results immediately after release (unlike Q3). GFCA should be teaching the CEO how to do things the proper way, seeing he has zero pubco experience as a CEO. IMO, this and his credibility have been the reasons why the pps stays at these levels.
Tut,
agreed, PIMD numbers are fantastic. excellent job to PIMD employees and sales team.
without an experienced mgmt team, post r/s, i believe the sp would come back to these levels. no pharma education and minimal pharma work experience would be the main reasons. imo
MARKETWIRED GET EMAIL ALERTS
PayChest Completes Designs for New Flushable & Biodegradable Adult Incontinence Product
By
Published: Nov 3, 2014 9:07 a.m. ET
0
HONG KONG, CHINA, Nov 03, 2014 (Marketwired via COMTEX) -- PayChest, Inc. (pinksheets:PYCT)
PayChest is pleased to announce that the Company, with its partners, have completed the design of its first flushable and biodegradable adult protection product.
This first product in PayChest's adult protection range is for light adult protection and will target the expanding "50 years or more" consumer market typified by baby boomers. Around one person in six that is 50 years or more uses some form of adult protection. Consumers typically use these light adult protection products to protect against urinary leaks caused by factors such as childbirth, diabetes, prostate problems, certain prescribed medicines and age related muscle control issues.
The superior discretion offered by a flushable adult protection product allows the consumer -- male and female -- to preserve their dignity and image of living a healthy and active lifestyle.
This new product draws on patents and designs currently owned or licensed by PayChest.
Together, the flushable and biodegradable adult protection range with the Mibella®/Flushaway® biodegradable and flushable womens sanitary product range provide the Company greater revenue potential, additional product lines and ultimately better revenue protection.
The Company expects to have prototypes available during the first quarter 2015, provided by Xinpro, our production partner that also manufactures the Mibella®/Flushaway® womens sanitary product range.
As more information comes available regarding the new product line, and any other developments, the Company will deliver this information to the market by news release. Those not currently on our e-mail list for news releases are encouraged to call or e-mail the company to be added.
NOTES ABOUT FORWARD-LOOKING STATEMENTS
Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's filings with OTC Markets http://www.otcmarkets.com/stock/PYCT/financials.
Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward looking statements because they involve unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made.
Historical news releases on the Company can be found at http://www.paychest.com/news.htm.
Contact:Â
Paychest, Inc.Â
ir@paychest.comÂ
Tom Hands:Â
1-416-619-5242
1-302-724-6944Â
SOURCE: PayChest, Inc.
mailto:ir@paychest.com